Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Jelic, S ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA INTERFERON; ANTHRACYCLINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; INTERFERON; SORAFENIB;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; FOLLOW UP; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

CARCINOMA, HEPATOCELLULAR; EUROPE; FOLLOW-UP STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; LIVER NEOPLASMS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 66549093572     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp124     Document Type: Article

References (21)

1. Tanaka H, Tsukuma H, Kasahara A et al. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients. Int J Cancer 2000; 87: 741-749.
2. Nishiguchi S, Kuroki T, Nakatani S et al. Randomised trial of effects of interferonalpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-1055.
3. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
4. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy. Hepatology 2000; 31: 1019-1021.
5. Leung TWT, Patt YZ, Lau W-Y et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999; 5: 1676-1681.
6. Bergsland EK, Venook AP. Hepatocellular carcinoma. Curr Opin Oncol 2000; 12: 357-361.
7. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
8. Simonetti RG, Camma C, Fiorello F et al. Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36: 962-972.
9. Sitzmann JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 1993; 217: 149-154.
10. Mathurin P, Rixe O, Carbonell N et al. Review article: Overview of medical treatments in unresectable hepatocellular carcinoma - an impossible meta-analysis? Aliment Pharmacol Ther 1998; 12: 11-126.
11. Tanaka K, Nakamura S, Numata K et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82: 8-85.
12. Fong Y, Sun RL, Jarnagin W et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-799.
13. Hemming AW, Cattral MS, Reed AI et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233: 652-659.
14. Pichlmayr R, Weimann A, Oldhafer KJ et al. Appraisal of transplantation for malignant tumors of the liver with special reference to early stage hepatocellular carcinoma. Eur J Surg Oncol 1998; 24: 60-67.
15. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998; 14: 171-174.
16. Llovet JM, Ricci S, Mazzaferro V et al. for the SHARP Investigators Study Group. Sorafenib in Advanced Hepatocellular Carcinoma. New Engl J Med 2008; 359(4): 378-390.
17. Yeo W, Mok TS, Zee B et al. A randomized phase III study of doxorubicin vs cisplatin/interferonalpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 2005; 97(20): 1532-1538.
18. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
19. Vogl T, Zangos S, Balzer J et al. Transarterial chemoembolization (TACE) in hepatocellular carcinoma: Technique, indication and results. Rofo 2007; 179(11): 1113-1126.
20. Livraghi T, Bolondi L, Lazzaroni S et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925-929.
21. Curley SA, Izzo F, Ellis LM et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391.